Pangenomic Health Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was CAD 11.99 million compared to CAD 2.65 million a year ago. Basic loss per share from continuing operations was CAD 0.22 compared to CAD 0.13 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | 0.00% | 0.00% | -60.00% |
Feb. 19 | PanGenomic Health plans to withdraw shares from Aquis Stock Exchange | AN |
Feb. 16 | Pangenomic Health Inc. Announces Changes to Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-60.00% | 615K | |
+4.71% | 32.58B | |
+16.26% | 7.65B | |
+21.60% | 3.92B | |
-15.80% | 3.19B | |
-27.19% | 1.26B | |
-33.58% | 1.14B | |
-33.74% | 926M | |
+1.56% | 908M | |
-23.93% | 859M |
- Stock Market
- Equities
- NARA Stock
- News Pangenomic Health Inc.
- Pangenomic Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022